Global oncology market is anticipated to reach USD 175.4 billion by 2020 growing at a CAGR of 7.1% during the forecasting period, 2020-2028. Oncology is one of the branches of medicine which deals prevention, diagnosis, and treatment of cancer. It includes the medical, surgical and radiation oncology. Medical oncology is of various types like chemotherapy, targeted therapy and immunotherapy. Factors such as increasing demand for minimally invasive procedures and the increasing number of targeted population are some of the major drivers for the oncology market
Global oncology market is segmented into areas, cancer type, treatment, technology, drugs, stage, end-user and geography.
Areas segment is segmented into Medical, Surgical and Radiation. Medical segment is further segmented into chemotherapy, Targeted Therapy and Immunotherapy. Surgical segment is further segmented into Image-Guided Biopsy, Fine Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Excisional Biopsy, Shave Biopsy, Punch Biopsy, Endoscopic Biopsy, Laparoscopic Biopsy, Bone Marrow Aspiration and Biopsy, Liquid Biopsy.
Cancer Type segment is segmented into Haematology Cancer, Ovarian Cancer, Pancreatic Cancer, Lung Cancer, Bladder Cancer, Prostate Cancer, Breast Cancer, Kidney Cancer and Others
Treatment segment is segmented into Combination Therapy, Adjuvant Therapy, Supportive Therapy, Palliative Care and Others
Technology segment is segmented into Car-T Cell Therapy, CRISPR/CAS9 and Others
Drugs segment is segmented into Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Imbruvica, Velcade, Zytiga, Xtandi and Others
Stage segment is segmented into Stage I, Stage II, Stage III and Stage IV
End Users segment is segmented into Hospitals, Specialty Clinics, Oncology Centers, Surgical Centers and Others.
Geographically, global oncology market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions
North America region is the largest contributor to the oncology market in the forecast period 2020-2028 and Asia-Pacific region is expected to grow with the highest CAGR during the forecast period 2020-2028.
Key players in global oncology market are Roche, BMS Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceuticals, Pfizer Inc., Eli Lilly, Merck & Co., Amgen, Abbvie, Allogene Therapeutics, Juno Therapeutics, Morphosys, Arcus Biosciences, Atreca, Autolus, Novocure among others
The companies have come up with various promotional activities in from of launch, investment, acquisition and other, for instance:
Hence, tremendous progress have been made over the last decade and yet a lot more to come in the recent years.
|
Report Features |
Description |
|---|---|
|
Market Revenue In 2020 |
USD 175.4 billion |
|
Growth Rate |
CAGR of 7.1% during the forecasting period, 2020-2028 |
|
Historical Data |
2017-2018 |
|
Forecast Years |
2020-2028 |
|
Base Year |
2019 |
|
Units Considered |
Revenue in USD billion and CAGR from 2020 to 2028 |
|
Report Segmentation |
Areas, Cancer Type, Treatment, Technology, Drugs, Stage, End-User and Geography |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and the Middle East and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
Roche, BMS Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceuticals, Pfizer Inc., Eli Lilly, Merck & Co., Amgen, Abbvie, Allogene Therapeutics, Juno Therapeutics, Morphosys, Arcus Biosciences, Atreca, Autolus, Novocure among others |
|
Available Customization |
In addition to the market data for the oncology market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
.png)
.png)
.png)
.png)
.png)
.png)